CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 84 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | – | 709 | +4964.3% | 0.00% | – |
| Q2 2022 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 14 | -99.8% | 0.00% | – |
| Q3 2021 | $39,000 | 0.0% | 6,168 | 0.0% | 0.00% | – |
| Q2 2021 | $39,000 | +1850.0% | 6,168 | +2290.7% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 258 | -29.3% | 0.00% | – |
| Q1 2020 | $2,000 | -98.5% | 365 | -97.8% | 0.00% | – |
| Q4 2019 | $137,000 | +13600.0% | 16,494 | +11354.2% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 144 | +61.8% | 0.00% | – |
| Q1 2018 | $2,000 | -60.0% | 89 | -69.3% | 0.00% | – |
| Q3 2017 | $5,000 | – | 290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |